HomeAI · summaries
Storia in 3 fonti
Some people are losing too much weight in Retatrutide trial.
Randomized trial results of the experimental GLP-1, GIP, and glucagon drug shows that it may be too effective, while causing a whopping 11% of participants at the highest dose to drop out because of the severity of the side effects. In Optimizer, Victoria Song covered TikTok influencers pushing grey market knockoffs of “Ratatouille” and attempted to find out what was actually in them. (Please don’t buy shady “Retatrutide” from the internet.)
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Retatrutide induces ‘impressive’ weight loss of up to 28.3% for adults with obesity
A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity, according to topline results from a phase 3 trial. As…
- ·
scientificamerican.com
Trial of next-gen weight-loss drug retatrutide shows users lose almost a third of their body weight
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
- ·
theverge.com
Some people are losing too much weight in Retatrutide trial.
Randomized trial results of the experimental GLP-1, GIP, and glucagon drug shows that it may be too effective, while causing a whopping 11% of participants at the highest dose to…